Tiopronin Tablets

Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CCl4 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio.

Tiopronin

This product is a white sugar-coated tablet, which appears white after removing the sugar coating.

Restore liver function and be used as an auxiliary treatment for chronic hepatitis.

Oral administration, 1-2 tablets (100-200ml) each time, 3 times a day, for 2-3 months or as directed by a doctor.

1. Digestive system: symptoms such as loss of appetite, nausea, vomiting, abdominal pain, diarrhea, etc. may occur occasionally, and abnormal taste is rare. You can reduce the dose or temporarily stop taking it. 2. Allergic reaction: Occasionally itching, rash, skin redness, etc., should stop taking this product. 3. Long-term and large-scale use rarely causes proteinuria or nephrotic syndrome, should reduce the dose or stop taking it. 4. Others: Rare insulin autoimmune syndrome, fatigue and limb numbness should be discontinued.

It is contraindicated for people who are allergic to this product. It is contraindicated for pregnant women, lactating women, and children.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Do not use in combination with drugs that have oxidizing effects.

Sealed, store in a cool and dry place

0.1g

24 months

Shanxi Tianzhi Pharmaceutical Co., Ltd.

• Founded in:

  2003-01-24

• Address:

  No. 7, Nanbei Street, Xinfu District, Xinzhou City, Shanxi Province (one license, multiple addresses)

• Tax NO.:

  91140902111893526T

• Registered Funds:

  133 million yuan

• Website:

  Log in to view

• Email:

  Log in to view